PMID- 25057926 OWN - NLM STAT- MEDLINE DCOM- 20150812 LR - 20211203 IS - 1540-0514 (Electronic) IS - 1073-2322 (Linking) VI - 43 IP - 1 DP - 2015 Jan TI - Extracellular signal-regulated kinase-mammalian target of rapamycin signaling and forkhead-box transcription factor 3a phosphorylation are involved in testosterone's effect on severe burn injury in a rat model. PG - 85-91 LID - 10.1097/SHK.0000000000000244 [doi] AB - BACKGROUND: Testosterone and androgen receptor agonists have been known for a long time to prevent or reverse muscle wasting in burn injury patients, but the exact molecular mechanisms are not clear. OBJECTIVE: To investigate the underlying molecular mechanisms of testosterone in severely burned rats. METHODS: Severe burn injuries were induced by immersing the back of the rat in 100 degrees C water for 12 s. Rats were treated for 14 days with vehicle (burn group) or a physiological replacement dose of testosterone (B + T group) immediately after injury. Gene and protein expressions were assessed by real-time polymerase chain reaction and Western blot. RESULTS: Testosterone improved glucose metabolism, reduced body weight loss, and attenuated tibialis anterior muscle mass loss and muscle protein breakdown. In rat tibialis anterior muscle, testosterone positively regulated the insulin-sensitive glucose transporters Glut3 and Glut4 genes and glycogen synthase 1 protein. These changes would be expected to improve glucose metabolism and nutrient availability in skeletal muscle. Administration of testosterone negatively regulated atrogin 1 (Fbxo32) by increasing total and phosphorylated Foxo3a (forkhead-box transcription factor 3a) levels and positively regulated the expression of the mammalian target of rapamycin (mTOR) and its downstream proteins p70S6 and S6 through mTOR-extracellular signal-regulated kinase phosphorylation. CONCLUSIONS: RESULTS suggested that testosterone might regulate skeletal muscle glucose and protein metabolism following burn injury in part by affecting extracellular signal-regulated kinase-mTOR signaling and Foxo3a levels. FAU - Ma, Li AU - Ma L AD - Department of Burns and Plastic Surgery, Burns Institute, First Hospital Affiliated to General Hospital of PLA, Beijing, China. FAU - Shen, Chuanan AU - Shen C FAU - Chai, Jiake AU - Chai J FAU - Yin, Huinan AU - Yin H FAU - Deng, Huping AU - Deng H FAU - Feng, Rui AU - Feng R LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Shock JT - Shock (Augusta, Ga.) JID - 9421564 RN - 0 (Androgens) RN - 0 (FOXO3 protein, rat) RN - 0 (Forkhead Box Protein O3) RN - 0 (Forkhead Transcription Factors) RN - 0 (Glucose Transporter Type 3) RN - 0 (Glucose Transporter Type 4) RN - 0 (Slc2a3 protein, rat) RN - 0 (Slc2a4 protein, rat) RN - 3XMK78S47O (Testosterone) RN - EC 2.7.1.1 (mTOR protein, rat) RN - EC 2.7.11.1 (Ribosomal Protein S6 Kinases, 70-kDa) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) RN - EC 2.7.11.24 (Extracellular Signal-Regulated MAP Kinases) RN - IY9XDZ35W2 (Glucose) SB - IM MH - Androgens/*pharmacology MH - Animals MH - Burns/*metabolism/pathology MH - Extracellular Signal-Regulated MAP Kinases/*metabolism MH - Forkhead Box Protein O3 MH - Forkhead Transcription Factors/*metabolism MH - Glucose/metabolism MH - Glucose Transporter Type 3/metabolism MH - Glucose Transporter Type 4/metabolism MH - MAP Kinase Signaling System/*drug effects MH - Male MH - Rats MH - Rats, Wistar MH - Ribosomal Protein S6 Kinases, 70-kDa/metabolism MH - TOR Serine-Threonine Kinases/*metabolism MH - Testosterone/*pharmacology EDAT- 2014/07/25 06:00 MHDA- 2015/08/13 06:00 CRDT- 2014/07/25 06:00 PHST- 2014/07/25 06:00 [entrez] PHST- 2014/07/25 06:00 [pubmed] PHST- 2015/08/13 06:00 [medline] AID - 10.1097/SHK.0000000000000244 [doi] PST - ppublish SO - Shock. 2015 Jan;43(1):85-91. doi: 10.1097/SHK.0000000000000244.